Fig. 5
From: Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma
Activity of rucaparib and SN-38 in SEC tumors ex vivo. PDX tumors were exposed to rucaparib, SN-38, or the combination at the indicated concentrations. PH537 (A) and PH658 (B) are highlighted due to their markedly different GIS results